You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

UROVIST SODIUM 300 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Urovist Sodium 300 patents expire, and when can generic versions of Urovist Sodium 300 launch?

Urovist Sodium 300 is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in UROVIST SODIUM 300 is diatrizoate sodium. There are eleven drug master file entries for this compound. Additional details are available on the diatrizoate sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for UROVIST SODIUM 300?
  • What are the global sales for UROVIST SODIUM 300?
  • What is Average Wholesale Price for UROVIST SODIUM 300?
Summary for UROVIST SODIUM 300
Drug patent expirations by year for UROVIST SODIUM 300

US Patents and Regulatory Information for UROVIST SODIUM 300

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare UROVIST SODIUM 300 diatrizoate sodium INJECTABLE;INJECTION 087725-001 Sep 23, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.